Login / Signup

A large remaining potential in lipid-lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort study.

Hanan AmadidPernille F RønnMaria Bekker-Nielsen DunbarJakob Schöllhammer KnudsenBendix CarstensenFrederik PerssonMarit E Jørgensen
Published in: Diabetes, obesity & metabolism (2021)
LLD use and LDL-C levels are far from optimal in the Danish type 2 diabetes population and improvement in LLD use could reduce ASCVD events.
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • emergency department
  • fatty acid
  • metabolic syndrome
  • human health